U.S. Food and Drug Administration (FDA)
See the following -
Global Personalized Medicine - Scientific And Commercial Aspects: Updated 2014 Report
Research and Markets has announced the addition of a new report "Personalized Medicine - Scientific and Commercial Aspects" to their offering...
- Login to post comments
Hepatitis C Drug Costing VA, DoD Millions
One of the costliest drugs on the market threatens the Veterans Affairs Department's health budget — to the point that VA, which added the medication to its formulary in April, provides it to only the sickest patients who need it...
- Login to post comments
HHS’ Cyber Threat Center Comes Out of Beta Soon
The Health and Human Services Department’s nascent cybersecurity center will soon reach initial operating capability to help share threat information with a sector constantly under attack and often short of cyber personnel of its own. Based on the Homeland Security Department's National Cybersecurity and Communications Integration Center, the Healthcare Cybersecurity Communications and Integration Center will share health-care specific threats information with other agencies and the private sector...
- Login to post comments
How A Small Group of Entrepreneurs Transformed Government Services
President Obama started with his own White House, recruiting Internet-savvy entrepreneurs to serve as chief technology officer (me), chief performance officer (Jeff Zients), chief information officer (Vivek Kundra) and director for social innovation (Sonal Shah), among other senior positions...
- Login to post comments
How Superbugs Hitch A Ride From Hog Farms Into Your Community
Factory-scale farms don't just house hundreds of genetically similar animals in tight quarters over vast cesspools collecting their waste...And when you dose the animals daily with small amounts of antibiotics—a common practice—the bacteria strains in these vast germ reservoirs quite naturally develop the ability to withstand anti-bacterial treatments...
- Login to post comments
How the healthcare system discourages creating low-cost solutions
The U.S. leads the world in creating new drugs and healthcare tech, but the system discourages inventors from creating cost-lowering technologies in favor of ones with a healthy return on investment, according to an article at the Journal of the American Medical Association. "In the United States, the surest way to generate a healthy return on investment is to increase health care spending, not reduce it," says the authors, from the Uniformed Services University of the Health Sciences and Yale School of Medicine.
- Login to post comments
IBM Watson Health Announces Collaboration to Study the Use of Blockchain Technology for Secure Exchange of Healthcare Data
IBM Watson Health has signed a research initiative with the U.S. Food and Drug Administration (FDA) aimed at defining a secure, efficient and scalable exchange of health data using blockchain technology. IBM and the FDA will explore the exchange of owner mediated data from several sources, such as Electronic Medical Records, clinical trials, genomic data, and health data from mobile devices, wearables and the “Internet of Things.” The initial focus will be on oncology-related data...
- Login to post comments
Investigating Blockchain's Role in Health Info Exchange
Federal regulators are considering the role that blockchain technology could play in advancing the secure exchange of healthcare information, says Steve Posnack of the Office of the National Coordinator for Health IT. Blockchain - an open source distributed ledger technology that's associated with the cryptocurrency bitcoin - "has a lot of different potential implementations, and I think its diversity in how it can be implemented is one of the attractive features. It's not just a one-trick pony," he says in an interview at the HIMSS17 conference in Orlando...
- Login to post comments
Is The US Meat Industry Pushing Us Into A ‘Post-Antibiotic Era’?
...Big Meat’s rampant use of antibiotics is one of the most worrying aspects of the meat industry, an issue that unites public health advocates, doctors, consumers, and others in shared concern...
- Login to post comments
Low-Carb on Trial (Galileo Had It Easy)
A recent exposé in the New York Times[1] revealed massive and pervasive fraud and collusion between the sugar industry and certain medical authorities in the 1960’s designed to erroneously promote saturated fat as the culprit behind heart disease. Effectively diverting attention from the real source of the problem (the increasing consumption of dietary sugar), the food industry conspired with key authorities within the medical establishment to serve their own best interests at the expense of public health. Historic documents showed that they were intentionally concealing the fact that sugar, instead of fat, was knowingly to blame...
- Login to post comments
Medidata And TransCelerate BioPharma Inc. Announce Joint Initiative
Collaboration to Explore Key Components of Recommended Risk-Based Monitoring Methodology
- Login to post comments
Mobile Health Apps Have Role In Ebola Crisis
Mobile health apps could play a bigger role than they have to date in speeding the response to a global health crisis...
- Login to post comments
Mobile Health Apps Have Role In Ebola Crisis
Mobile health apps could play a bigger role than they have to date in speeding the response to a global health crisis...
- Login to post comments
Modified Maggots Could Help Human Wound Healing
In a proof-of-concept study, NC State University researchers show that genetically engineered green bottle fly (Lucilia sericata) larvae can produce and secrete a human growth factor - a molecule that helps promote cell growth and wound healing. Sterile, lab-raised green bottle fly larvae are used for maggot debridement therapy (MDT), in which maggots are applied to non-healing wounds, especially diabetic foot ulcers, to promote healing. Maggots clean the wound, remove dead tissue and secrete anti-microbial factors. The treatment is cost-effective and approved by the Food and Drug Administration...
- Login to post comments
New Path for Drug Development
The 1960s was a decade that witnessed humans setting foot on the moon and a bloody war that changed the history. In between these events, a drug that would be the mainstay for doctors for decades to fight a smart bug, was born. Rifampicin was the last novel class of antibiotics against Mycobacterium tuberculosis till the arrival of bedaquiline at the fag end of 2012. Discovered in 1965, Rifampicin was marketed in Italy in 1968 and was approved by the US regulatory body in 1971...
- Login to post comments